NEW YORK (Genomeweb) — A study comprehensively analyzing the genomes of more than 1,500 neuroblastoma cases has better determined the prognostic significance of ALK mutations and other alterations in neuroblastoma, and has biochemically investigated many of these variants to determine which ones

NEW YORK (GenomeWeb) – Qiagen today said that it has signed a master collaboration agreement to develop and commercialize companion diagnostics for existing Novartis products as well as compounds in Novartis' development pipeline.

Originally published Nov. 10.
NEW YORK (GenomeWeb) – Consulting firm Diaceutics has released a report that shows pharmaceutical companies' readiness to develop and deliver personalized medicines has improved since 2010, at least according to the numbers.

NEW YORK (GenomeWeb) – During its fiscal third quarter, Thermo Fisher Scientific took $12.8 million in charges related to severance, the company disclosed in its Form 10-Q filed recently with the US Securities and Exchange Commission.

Enterome Bioscience is collaborating with AbbVie to create molecular diagnostic tools to monitor the gut microbiome in patients with Crohn's disease and other microbiome-related diseases.

Originally published Nov. 10.

NEW YORK (GenomeWeb) – Quest Diagnostics last week launched BRCAvantage Plus, a testing service for gauging breast cancer risk through which patients can learn whether they harbor mutations in BRCA and other genes.

Vanderbilt University has appointed Nancy Cox the founding director of the new Vanderbilt Genetics Institute, effective Jan. 1, 2015. She also will be a professor of genetics and direct the division of genetic medicine in the department of medicine.

NEW YORK (GenomeWeb) – Genomics England today announced the launch of the Clinical Interpretation Partnership (GeCIP) to bring together UK researchers and the National Health Service to translate findings from the 100,000 Genomes Project for use in the early diagnosis of diseases.

NEW YORK (GenomeWeb) – Vela Diagnostics said today that it has completed the listing of its next-generation sequencing system with the US Food and Drug Administration as a class II medical device.

Pages

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.